Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vector development: a major obstacle in human gene therapy

S M Jane, J M Cunningham, E F Vanin

    Annals of Medicine
    |November 14, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study.

    Geburtshilfe und Frauenheilkunde·2017
    Same author

    Grainyhead-like Transcription Factors in Craniofacial Development.

    Journal of dental research·2017
    Same author

    Effects of high and low sodium diet on blood pressure and heart rate in mice lacking the functional grainyhead-like 1 gene.

    Physiological research·2016
    Same author

    Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling.

    Leukemia·2016
    Same author

    The role of barrier genes in epidermal malignancy.

    Oncogene·2016
    Same author

    Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.

    Translational psychiatry·2014
    Same journal

    Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial.

    Annals of medicine·2026
    Same journal

    Postoperative outcomes of on- vs off-pump CABG in patients with HFrEF: a nationwide cohort study in Taiwan.

    Annals of medicine·2026
    Same journal

    Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal function.

    Annals of medicine·2026
    Same journal

    Association of neutrophil percentage-to-albumin ratio with sepsis in infant.

    Annals of medicine·2026
    Same journal

    Enhancing Hemoglobin Bart's hydrops fetalis syndrome prevention: a single-tube multiplex real-time PCR assay for the comprehensive detection of four significant α<sup>0</sup>-thalassemia deletions (--<sup>SEA</sup>, --<sup>THAI</sup>, --<sup>CR</sup>, and --<sup>SA</sup>) found in Thailand.

    Annals of medicine·2026
    Same journal

    Association of non-insulin-based insulin resistance indices with the risk of aortic stenosis progression in patients with mild or moderate aortic stenosis.

    Annals of medicine·2026
    See all related articles

    Gene therapy offers potential for various diseases, but effective gene delivery and expression remain challenges. Overcoming these hurdles requires developing advanced vectors for successful human applications.

    Area of Science:

    • Biomedical Science
    • Molecular Biology
    • Genetics

    Background:

    • Gene therapy is a promising approach for treating genetic disorders, cancer, and other diseases.
    • Successful gene therapy requires intact gene delivery, sustained expression, and minimal side effects.

    Discussion:

    • Significant progress in animal models contrasts with persistent obstacles in human gene therapy.
    • Early gene therapy vectors faced challenges in overcoming biological hurdles for effective treatment.

    Key Insights:

    • Vector development is a critical bottleneck for advancing human gene therapy.
    • First-generation vectors have not fully addressed the complexities of in vivo gene transfer and expression.

    Outlook:

    Related Experiment Videos

  • Development of novel gene delivery systems is essential for overcoming current limitations.
  • Future research must focus on creating safer and more efficient vectors for widespread therapeutic use.